Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 141 citing articles:

Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7C
Karen S. Tiley, Helen Ratcliffe, Merryn Voysey, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 5, pp. 610-621
Open Access | Times Cited: 26
Role of toll-like receptors and nod-like receptors in acute lung infection
John Le, Yathushigan Kulatheepan, Samithamby Jeyaseelan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006‒2022
Catherine Hyams, Robert Challen, David Hettle, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 10
Open Access | Times Cited: 14
Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults ≥65 years old
David Fitzpatrick, Mariano Young, Kari Yacisin, et al.
Vaccine (2023) Vol. 41, Iss. 28, pp. 4190-4198
Open Access | Times Cited: 13
Multiplex real-time PCR in non-invasive respiratory samples to reduce antibiotic use in community-acquired pneumonia: a randomised trial
Gabriela Abelenda-Alonso, Laura Calatayud, Alexander Rombauts, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis
Maria Garcia Quesada, Meagan E. Peterson, Julia C. Bennett, et al.
The Lancet Infectious Diseases (2024)
Open Access | Times Cited: 4
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age
Matt Wasserman, Johnna Perdrizet, Lindsay R. Grant, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 2701-2720
Open Access | Times Cited: 31
Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: Nationwide surveillance from 2007 to 2019
Maria‐Cristina C. Brandileone, Samanta Cristine Grassi Almeida, Sérgio Bokermann, et al.
Vaccine (2021) Vol. 39, Iss. 23, pp. 3207-3215
Closed Access | Times Cited: 29
Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong
Jade L. L. Teng, Kenny M. N. Fok, Ken P. K. Lin, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 2, pp. 335-338
Open Access | Times Cited: 28
Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic
Vincent Chi‐Chung Cheng, Shuk‐Ching Wong, Simon Yung-Chun So, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 746-746
Open Access | Times Cited: 20
Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic
Stefanie Völk, Markus Pfirrmann, Uwe Koedel, et al.
Journal of Neurology (2022) Vol. 269, Iss. 7, pp. 3389-3399
Open Access | Times Cited: 19
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study
Catherine Hyams, Robert Challen, Elizabeth Begier, et al.
The Lancet Regional Health - Europe (2022) Vol. 21, pp. 100473-100473
Open Access | Times Cited: 19
Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults
Anna M Parker, Nicole Jackson, Shevya Awasthi, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 7, pp. 1209-1217
Open Access | Times Cited: 19
Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemic
Aleksandra Kovacevic, David R. Smith, Eve Rahbé, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 3
Prevention and treatment of infection in patients with an absent or hypofunctional spleen: A British Society for Haematology guideline
Shamez Ladhani, Savio Fernandes, Mamta Garg, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1672-1686
Open Access | Times Cited: 3
Non-pharmaceutical interventions for COVID-19 transiently reduced pneumococcal and Haemophilus influenzae carriage in a cross-sectional pediatric cohort in Southampton, UK
David Cleary, James Campling, María Lahuerta, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 8
Open Access | Times Cited: 3
Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa
Ben Morton, Kayla G. Barnes, Catherine Anscombe, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 26
The impact of COVID-19 on routine vaccinations in Taiwan and an unexpected surge of pneumococcal vaccination
Nan‐Chang Chiu, Kai-Hsun Lo, Chung-Chu Chen, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 17
Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection
Eileen M. Dunne, Marta C. Nunes, Mary Slack, et al.
Pneumonia (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults
Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, et al.
Vaccine (2023) Vol. 41, Iss. 30, pp. 4431-4437
Closed Access | Times Cited: 9
Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths
Robert Root‐Bernstein
Vaccines (2021) Vol. 9, Iss. 5, pp. 474-474
Open Access | Times Cited: 20
Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2
Amanda Smith, Evan P. Williams, Taylor R. Plunkett, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Coronavirus disease 2019 (COVID-19): Secondary bacterial infections and the impact on antimicrobial resistance during the COVID-19 pandemic
Yelena Markovskaya, Elizabeth M. Gavioli, Jaclyn A. Cusumano, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 15
Decreased Pneumococcal Carriage Among Older Adults in Denmark During the COVID-19 Lockdown
Michaela Tinggaard, Hans‐Christian Slotved, Randi Føns Petersen, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 8
Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein
Maritza J. Romero, Yue Qian, Bhupesh Singla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8

Scroll to top